Fluorescence in situ hybridization microscopic detection of Bacilli Calmette Guérin mycobacteria in aortic lesions: A case report

Medicine (Baltimore). 2018 Jul;97(30):e11321. doi: 10.1097/MD.0000000000011321.

Abstract

Rationale: To improve the diagnosis of life-threatening Bacilli Calmette Guérin (BCG) arterial aneurysm in patients treated by intravesical instillation of BCG vaccine as adjunctive therapy for non-muscular bladder carcinoma, is a life-threatening condition. Its diagnosis remains cumbersome.

Patient concerns: One patient with a history of intravesical BCG installation presented with aortic aneurysm with routine microscopic examination after Ziehl-Neelsen staining remaining negative.

Diagnoses: We used fluorescence in situ hybridization (FISH) to target the Mycobacterium tuberculosis complex rpob gene in a fresh aortic specimen. FISH yielded fluorescent mycobacteria in aortic lesions; mycobacteria were further confirmed as Mycobacterium bovis BCG mycobacteria by polymerase chain reaction (PCR) sequencing.

Interventions: The patient benefited from an antituberculous treatment combining rifampicin, isoniazid, and ethambunol.

Outcome: A 9-month follow-up indicated a favorable outcome.

Lessons: This case report teaches that FISH targeting the M tuberculosis complex rpoB gene should be incorporated in the laboratory investigation of aortic aneurysm in patients with a history of bladder carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / adverse effects
  • Administration, Intravesical
  • Aged
  • Aortic Aneurysm, Abdominal* / diagnosis
  • Aortic Aneurysm, Abdominal* / etiology
  • Aortic Aneurysm, Abdominal* / microbiology
  • Aortic Aneurysm, Abdominal* / physiopathology
  • BCG Vaccine* / administration & dosage
  • BCG Vaccine* / adverse effects
  • Humans
  • In Situ Hybridization, Fluorescence / methods*
  • Male
  • Microscopy, Fluorescence / methods*
  • Mycobacterium bovis / isolation & purification*
  • Reproducibility of Results
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Adjuvants, Immunologic
  • BCG Vaccine